FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091973648> ?p ?o ?g. }

• W2091973648 endingPage "289" @default.
• W2091973648 startingPage "284" @default.
• W2091973648 abstract "Cetuximab and docetaxel have single-agent activity in squamous cell carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated in platinum-pretreated patients with recurrent and/or metastatic SCCHN.A total of 84 patients were treated with docetaxel 35 mg/m(2) weekly for a maximum of 6 cycles and concomitant cetuximab 250 mg/m(2) weekly until disease progression or unacceptable toxicity. The primary endpoint was the objective response rate and secondary endpoints included the response rate in relation to platinum sensitivity, progression-free survival (PFS), overall survival (OS) and toxicity.Nine (11%) patients achieved a partial response and 34 (40%) stable disease, resulting in a disease control rate of 51%. Response to treatment was 49% in previously platinum-sensitive and 50% in previously platinum-resistant disease. The median PFS was 3.1 months and the median OS 6.7 months. The most common grade 3 or 4 adverse events were mucositis (8%), pneumonia (8%), fatigue (8%) and skin reactions (14%). Sepsis occurred in 3 patients.Cetuximab plus docetaxel is an active treatment regimen with moderate toxicity in SCCHN patients. However, no superiority in comparison with monotherapy could be shown. Responsiveness and survival were independent of previous platinum sensitivity." @default.
• W2091973648 created "2016-06-24" @default.
• W2091973648 creator A5015232096 @default.
• W2091973648 creator A5017638217 @default.
• W2091973648 creator A5028867235 @default.
• W2091973648 creator A5038597396 @default.
• W2091973648 creator A5044553314 @default.
• W2091973648 creator A5047006205 @default.
• W2091973648 creator A5050243478 @default.
• W2091973648 creator A5054422040 @default.
• W2091973648 creator A5066640097 @default.
• W2091973648 creator A5068212826 @default.
• W2091973648 creator A5071766547 @default.
• W2091973648 creator A5074573810 @default.
• W2091973648 creator A5088397986 @default.
• W2091973648 date "2013-01-01" @default.
• W2091973648 modified "2023-10-01" @default.
• W2091973648 title "Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie" @default.
• W2091973648 cites W135877420 @default.
• W2091973648 cites W1978068596 @default.
• W2091973648 cites W1978758070 @default.
• W2091973648 cites W2004950002 @default.
• W2091973648 cites W2035765221 @default.
• W2091973648 cites W2063721051 @default.
• W2091973648 cites W2068125497 @default.
• W2091973648 cites W2074099831 @default.
• W2091973648 cites W2093061305 @default.
• W2091973648 cites W2105499277 @default.
• W2091973648 cites W2112845420 @default.
• W2091973648 cites W2118458295 @default.
• W2091973648 cites W2130930654 @default.
• W2091973648 cites W2136871952 @default.
• W2091973648 cites W2151268072 @default.
• W2091973648 cites W2156071539 @default.
• W2091973648 cites W2170517479 @default.
• W2091973648 cites W2240385959 @default.
• W2091973648 doi "https://doi.org/10.1159/000345453" @default.
• W2091973648 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23445718" @default.
• W2091973648 hasPublicationYear "2013" @default.
• W2091973648 type Work @default.
• W2091973648 sameAs 2091973648 @default.
• W2091973648 citedByCount "38" @default.
• W2091973648 countsByYear W20919736482013 @default.
• W2091973648 countsByYear W20919736482014 @default.
• W2091973648 countsByYear W20919736482015 @default.
• W2091973648 countsByYear W20919736482016 @default.
• W2091973648 countsByYear W20919736482017 @default.
• W2091973648 countsByYear W20919736482018 @default.
• W2091973648 countsByYear W20919736482019 @default.
• W2091973648 countsByYear W20919736482020 @default.
• W2091973648 countsByYear W20919736482021 @default.
• W2091973648 countsByYear W20919736482022 @default.
• W2091973648 crossrefType "journal-article" @default.
• W2091973648 hasAuthorship W2091973648A5015232096 @default.
• W2091973648 hasAuthorship W2091973648A5017638217 @default.
• W2091973648 hasAuthorship W2091973648A5028867235 @default.
• W2091973648 hasAuthorship W2091973648A5038597396 @default.
• W2091973648 hasAuthorship W2091973648A5044553314 @default.
• W2091973648 hasAuthorship W2091973648A5047006205 @default.
• W2091973648 hasAuthorship W2091973648A5050243478 @default.
• W2091973648 hasAuthorship W2091973648A5054422040 @default.
• W2091973648 hasAuthorship W2091973648A5066640097 @default.
• W2091973648 hasAuthorship W2091973648A5068212826 @default.
• W2091973648 hasAuthorship W2091973648A5071766547 @default.
• W2091973648 hasAuthorship W2091973648A5074573810 @default.
• W2091973648 hasAuthorship W2091973648A5088397986 @default.
• W2091973648 hasBestOaLocation W20919736482 @default.
• W2091973648 hasConcept C121608353 @default.
• W2091973648 hasConcept C126322002 @default.
• W2091973648 hasConcept C143998085 @default.
• W2091973648 hasConcept C203092338 @default.
• W2091973648 hasConcept C2776530083 @default.
• W2091973648 hasConcept C2776694085 @default.
• W2091973648 hasConcept C2776833033 @default.
• W2091973648 hasConcept C2777063308 @default.
• W2091973648 hasConcept C2778424827 @default.
• W2091973648 hasConcept C2778496288 @default.
• W2091973648 hasConcept C2779998722 @default.
• W2091973648 hasConcept C2781190966 @default.
• W2091973648 hasConcept C2781413609 @default.
• W2091973648 hasConcept C31760486 @default.
• W2091973648 hasConcept C509974204 @default.
• W2091973648 hasConcept C526805850 @default.
• W2091973648 hasConcept C535046627 @default.
• W2091973648 hasConcept C71924100 @default.
• W2091973648 hasConcept C90924648 @default.
• W2091973648 hasConceptScore W2091973648C121608353 @default.
• W2091973648 hasConceptScore W2091973648C126322002 @default.
• W2091973648 hasConceptScore W2091973648C143998085 @default.
• W2091973648 hasConceptScore W2091973648C203092338 @default.
• W2091973648 hasConceptScore W2091973648C2776530083 @default.
• W2091973648 hasConceptScore W2091973648C2776694085 @default.
• W2091973648 hasConceptScore W2091973648C2776833033 @default.
• W2091973648 hasConceptScore W2091973648C2777063308 @default.
• W2091973648 hasConceptScore W2091973648C2778424827 @default.
• W2091973648 hasConceptScore W2091973648C2778496288 @default.
• W2091973648 hasConceptScore W2091973648C2779998722 @default.
• W2091973648 hasConceptScore W2091973648C2781190966 @default.

• next